Pure Red Blood Cell Aplasia and Isoniazid Use
Pierre Loulergue +2 more
doaj +1 more source
Daratumumab for treatment-refractory acquired idiopathic pure red cell aplasia
Naseema Gangat +5 more
doaj +1 more source
Roxadustat in the Treatment of Pure Red Cell Aplasia Associated With Anti-EPO Antibodies. [PDF]
Serrano B +5 more
europepmc +1 more source
Monoclonal Gammopathy as a Potential Cause of Pure Red Cell Aplasia: A Case Report and Literature Review. [PDF]
De Weerdt P, Van Riet I, Fostier K.
europepmc +1 more source
Ectopic Cervical Thymoma with Myasthenia Gravis and Pure Red Cell Aplasia: A Case Report. [PDF]
Narusawa E +9 more
europepmc +1 more source
Sirolimus plus roxadustat synergistically enhances immunosuppression and erythropoiesis in pure red cell aplasia: a multicenter trial. [PDF]
Wang H +25 more
europepmc +1 more source
Acquired Pure Red Cell Aplasia Following BNT162b2 mRNA COVID-19 Vaccination. [PDF]
Hayase N +3 more
europepmc +1 more source
Phagocytosis of Lymphocytes and Erythrocytes by B-Cell Lymphoma in a Patient With a Clinical Suspicion of Pure Red Cell Aplasia. [PDF]
Cao T, Li Y, Peng X.
europepmc +1 more source
Successful Treatment of Posttransplant Refractory Pure Red Cell Aplasia Following Parvovirus B19 Infection. [PDF]
Ansara Y +6 more
europepmc +1 more source

